Animal peptides targeting voltage-activated sodium channels

Current Pharmaceutical Design

Volumn 14, Issue 24, 2008, Pages 2492-2502

  Billen, Bert ^a   Bosmans, Frank ^a,b   Tytgat, Jan ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Conus; Scorpion; Sodium channel; Spider; Toxin

Indexed keywords

BMK AEP TOXIN; BMK ANGP1 TOXIN; BMK AS TOXIN; BMK AS1 TOXIN; BMK DIT AP3 TOXIN; BMK IT AP TOXIN; BMK IT2 TOXIN; BMK TOXIN; CCOTX1 TOXIN; CCOTX3 TOXIN; CLL9 TOXIN; CONOTOXIN; HAINANTOXIN III; HAINANTOXIN IV; HUWENTOXIN IV; JINGZHAOTOXIN I; JINGZHAOTOXIN III; OMEGA AGATOXIN; OMEGA ATRACOTOXIN; PNTX2 TOXIN; PROTX II TOXIN; PROTX1 TOXIN; SCORPION VENOM; SNAIL VENOM; SNX 482; SODIUM CHANNEL BLOCKING AGENT; SPIDER VENOM; UNCLASSIFIED DRUG; UNINDEXED DRUG; VENOM; VOLTAGE GATED SODIUM CHANNEL;

ANALGESIC ACTIVITY; ANTICONVULSANT ACTIVITY; DRUG BINDING SITE; DRUG ISOLATION; DRUG RECEPTOR BINDING; DRUG TARGETING; EPILEPSY; HUMAN; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; REVIEW;

ANIMALS; DRUG DESIGN; HUMANS; MOLLUSK VENOMS; PEPTIDES; SCORPION VENOMS; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS; SPIDER VENOMS; VENOMS;

EID: 52949131528     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208785777423     Document Type: Review

References (200)

1. Gotti C, Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol 2004; 74: 363-96.
2. Lewis RJ, Garcia ML. Therapeutic potential of venom peptides. Nat Rev Drug Discov 2003; 2: 790-802.
3. Clapham DE. SnapShot: mammalian TRP channels. Cell 2007; 129: 220.
4. Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J. International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol Rev 2005; 57: 411-25.
5. + channels. Ann N Y Acad Sci 1999; 868: 233-85.
6. Gutman GA, Chandy KG, Grissmer S, Lazdunski M, McKinnon D, Pardo LA, et al. International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol Rev 2005; 57: 473-508.
7. Diochot S, Salinas M, Baron A, Escoubas P, Lazdunski M. Peptides inhibitors of acid-sensing ion channels. Toxicon 2007; 49: 271-84.
8. Jasti J, Furukawa H, Gonzales EB, Gouaux E. Structure of acid-sensing ion channel 1 at 1.9 A resolution and low pH. Nature 2007; 449: 316-23.
9. Lesage F, Lazdunski M. Molecular and functional properties of two-pore-domain potassium channels. Am J Physiol Renal Physiol 2000; 279: 793-801.
10. Ostrow KL, Mammoser A, Suchyna T, Sachs F, Oswald R, Kubo S, et al. cDNA sequence and in vitro folding of GsMTx4, a specific peptide inhibitor of mechanosensitive channels. Toxicon 2003; 42: 263-74.
11. Siemens J, Zhou S, Piskorowski R, Nikai T, Lumpkin EA, Basbaum AI, et al. Spider toxins activate the capsaicin receptor to produce inflammatory pain. Nature 2006; 444: 208-12.
12. + channel-blocking peptides. Neuron 1995; 15: 5-10.
13. Bourinet E, Stotz SC, Spaetgens RL, Dayanithi G, Lemos J, Nargeot J, et al. Interaction of SNX482 with domains III and IV inhibits activation gating of alpha(1E) (Cav2.3) calcium channels. Biophys J 2001; 81: 79-88.
14. Corzo G, Escoubas P, Villegas E, Karbat I, Gordon D, Gurevitz M, et al. A spider toxin that induces a typical effect of scorpion alpha-toxins but competes with beta-toxins on binding to insect sodium channels. Biochemistry 2005; 44: 1542-9.
15. Koppenhofer E, Schmidt H. Effect of scorpion venom on ionic currents of the node of Ranvier. II. Incomplete sodium inactivation. Pflugers Arch 1968; 303: 150-61.
16. Koppenhofer E, Schmidt H. Effect of scorpion venom on ionic currents of the node of Ranvier. I. The permeabilities PNa and PK. Pflugers Arch 1968; 303: 133-49.
17. + channels. Proc Natl Acad Sci USA 1998; 95: 8585-9.
18. Middleton RE, Warren VA, Kraus RL, Hwang JC, Liu CJ, Dai G, et al. Two tarantula peptides inhibit activation of multiple sodium channels. Biochemistry 2002; 41: 14734-47.
19. Swartz KJ, MacKinnon R. An inhibitor of the Kv2.1 potassium channel isolated from the venom of a Chilean tarantula. Neuron 1995; 15: 941-9.
20. Yu FH, Westenbroek RE, Silos-Santiago I, McCormick KA, Lawson D, Ge P, et al. Sodium channel beta4, a new disulfide-linked auxiliary subunit with similarity to beta2. J Neurosci 2003; 23: 7577-85.
21. Yu FH, Catterall WA. Overview of the voltage-gated sodium channel family. Genome Biol 2003; 4: 207.
22. Catterall WA. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 2000; 26: 13-25.
23. Stuhmer W, Conti F, Suzuki H, Wang XD, Noda M, Yahagi N, et al. Structural parts involved in activation and inactivation of the sodium channel. Nature 1989; 339: 597-603.
24. Chanda B, Bezanilla F. Tracking voltage-dependent conformational changes in skeletal muscle sodium channel during activation. J Gen Physiol 2002; 120: 629-45.
25. Catterall WA, Goldin AL, Waxman SG. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev 2005; 57: 397-409.
26. Goldin AL. Resurgence of sodium channel research. Annu Rev Physiol 2001; 63: 871-94.
27. Isbister GK, White J. Clinical consequences of spider bites: recent advances in our understanding. Toxicon 2004; 43: 477-92.
28. Nicholson GM, Graudins A. Spiders of medical importance in the Asia-Pacific: atracotoxin, latrotoxin and related spider neurotoxins. Clin Exp Pharmacol Physiol 2002; 29: 785-94.
29. Escoubas P, Diochot S, Corzo G. Structure and pharmacology of spider venom neurotoxins. Biochimie 2000; 82: 893-907.
30. Rash LD, Hodgson WC. Pharmacology and biochemistry of spider venoms. Toxicon 2002; 40: 225-54.
31. Nicholson GM. Spider venom peptides. In: Kastin A Ed, The handbook of biologically active peptides. San diego, Elsevier 2006; 369-79.
32. Grishin E. Polypeptide neurotoxins from spider venoms. Eur J Biochem 1999; 264: 276-80.
33. Pimenta AM, De Lima ME. Small peptides, big world: biotechnological potential in neglected bioactive peptides from arthropod venoms. J Pept Sci 2005; 11: 670-6.
34. Branton WD, Rudnick MS, Zhou Y, Eccleston ED, Fields GB, Bowers LD. Fatty acylated toxin structure. Nature 1993; 365: 496-7.
35. Norton RS, Pallaghy PK. The cystine knot structure of ion channel toxins and related polypeptides. Toxicon 1998; 36: 1573-83.
36. Wang X, Connor M, Smith R, Maciejewski MW, Howden ME, Nicholson GM, et al. Discovery and characterization of a family of insecticidal neurotoxins with a rare vicinal disulfide bridge. Nat Struct Biol 2000; 7: 505-13.
37. Craik DJ, Daly NL, Waine C. The cystine knot motif in toxins and implications for drug design. Toxicon 2001; 39: 43-60.
38. Liang S. An overview of peptide toxins from the venom of the Chinese bird spider Selenocosmia huwena Wang [≈ Ornithoctonus huwena (Wang)]. Toxicon 2004; 43: 575-85.
39. + channels by two spider toxins: hainantoxin-III and hainantoxin-IV. Eur J Pharmacol 2003; 477: 1-7.
40. Corzo G, Gilles N, Satake H, Villegas E, Dai L, Nakajima T, et al. Distinct primary structures of the major peptide toxins from the venom of the spider Macrothele gigas that bind to sites 3 and 4 in the sodium channel. FEBS Lett 2003; 547: 43-50.
41. Matavel A, Cruz JS, Penaforte CL, Araujo DA, Kalapothakis E, Prado VF, et al. Electrophysiological characterization and molecular identification of the Phoneutria nigriventer peptide toxin PnTx2-6. FEBS Lett 2002; 523: 219-23.
42. Xiao Y, Tang J, Hu W, Xie J, Maertens C, Tytgat J, et al. Jingzhaotoxin-I, a novel spider neurotoxin preferentially inhibiting cardiac sodium channel inactivation. J Biol Chem 2005; 280: 12069-76.
43. Xiao Y, Tang J, Yang Y, Wang M, Hu W, Xie J, et al. Jingzhaotoxin-III, a novel spider toxin inhibiting activation of voltage-gated sodium channel in rat cardiac myocytes. J Biol Chem 2004; 279: 26220-6.
44. Adams ME. Agatoxins: ion channel specific toxins from the American funnel web spider, Agelenopsis aperta. Toxicon 2004; 43: 509-25.
45. Corzo G, Escoubas P, Stankiewicz M, Pelhate M, Kristensen CP, Nakajima T. Isolation, synthesis and pharmacological characterization of delta-palutoxins IT, novel insecticidal toxins from the spider Paracoelotes luctuosus (Amaurobiidae). Eur. J. Biochem. 2000; 267: 5783-95.
46. Corzo G, Sabo JK, Bosmans F, Billen B, Villegas E, Tytgat J, et al. Solution structure and alanine scan of a spider toxin that affects the activation of mammalian voltage-gated sodium channels. J Biol Chem 2007; 282: 4643-52.
47. Escoubas P, Rash L. Tarantulas: eight-legged pharmacists and combinatorial chemists. Toxicon 2004; 43: 555-74.
48. + channels of chromaffin cells. Eur J Pharmacol 2003; 475: 11-8.
49. Chong Y, Hayes JL, Sollod B, Wen S, Wilson DT, Hains PG, et al. The omega-atracotoxins: selective blockers of insect M-LVA and HVA calcium channels. Biochem Pharmacol 2007; 74: 623-38.
50. + currents in neurosecretory insect neurons. Recept Chan 1998; 5: 355-66.
51. Posokhov YO, Gottlieb PA, Morales MJ, Sachs F, Ladokhin AS. Is lipid bilayer binding a common property of inhibitor cysteine knot ion-channel blockers? Biophys J 2007; 93: L20-2.
52. Swartz KJ. Tarantula toxins interacting with voltage sensors in potassium channels. Toxicon 2007; 49: 213-30.
53. Cohen L, Gilles N, Karbat I, Ilan N, Gordon D, Gurevitz M. Direct evidence that receptor site-4 of sodium channel gating modifiers is not dipped in the phospholipid bilayer of neuronal membranes. J Biol Chem 2006; 281: 20673-9.
54. Lee CW, Kim S, Roh SH, Endoh H, Kodera Y, Maeda T, et al. Solution structure and functional characterization of SGTx1, a modifier of Kv2.1 channel gating. Biochemistry 2004; 43: 890-7.
55. + channels and related peptides: biodiversity, structure-function relationships and evolution. Toxicon 2005; 46: 831-44.
56. de la Vega RC, Possani LD. Novel paradigms on scorpion toxins that affects the activating mechanism of sodium channels. Toxicon 2007; 49: 171-80.
57. +-channels. Eur J Biochem 1999; 264: 287-300.
58. Possani LD, Merino E, Corona M, Bolivar F, Becerril B. Peptides and genes coding for scorpion toxins that affect ion-channels. Biochimie 2000; 82: 861-8.
59. +-channels. Toxicon 2004; 43: 865-75.
60. Srinivasan KN, Gopalakrishnakone P, Tan PT, Chew KC, Cheng B, Kini RM, et al. SCORPION, a molecular database of scorpion toxins. Toxicon 2002; 40: 23-31.
61. Jungo F, Bairoch A. Tox-Prot, the toxin protein annotation program of the Swiss-Prot protein knowledgebase. Toxicon 2005; 45: 293-301.
62. Goudet C, Chi CW, Tytgat J. An overview of toxins and genes from the venom of the Asian scorpion Buthus martensi Karsch. Toxicon 2002; 40: 1239-58.
63. Muller GJ. Scorpionism in South Africa. A report of 42 serious scorpion envenomations. South African Med J 1993; 83: 405-11.
64. Debont T, Swerts A, Van der Walt JJ, Muller GJ, Verdonck F, Daenens P, et al. Comparison and characterization of the venoms of three Parabuthus scorpion species occurring in southern Africa. Toxicon 1998; 36: 341-52.
65. Kopeyan C, Mansuelle P, Sampieri F, Brando T, Bahraoui EM, Rochat H, et al. Primary structure of scorpion anti-insect toxins isolated from the venom of Leiurus quinquestriatus quinquestriatus. FEBS Lett 1990; 261: 423-6.
66. Rochat C, Rochat H, Miranda F, Lissitzky S. Purification of scorpion's neurotoxins Androctonus australis. Mem Inst Butantan 1966; 33: 447-52.
67. Possani LD, Alagon AC, Fletcher PL Jr, Erickson BW. Purification and properties of mammalian toxins from the venom of Brazilian Scorpion Tityus serrulatus Lutz and Mello. Arch Biochem Biophys 1977; 180: 394-403.
68. Becerril B, Marangoni S, Possani LD. Toxins and genes isolated from scorpions of the genus Tityrus. Toxicon 1997; 35: 821-35.
69. + channels. Toxicon 2007; 49: 550-60.
70. Little MJ, Wilson H, Zappia C, Cestele S, Tyler MI, Martin-Eauclaire MF, et al. Delta-atracotoxins from Australian funnel-web spiders compete with scorpion alpha-toxin binding on both rat brain and insect sodium channels. FEBS Lett 1998; 439: 246-52.
71. Little MJ, Zappia C, Gilles N, Connor M, Tyler MI, Martin-Eauclaire MF, et al. Delta-Atracotoxins from australian funnel-web spiders compete with scorpion alpha-toxin binding but differentially modulate alkaloid toxin activation of voltage-gated sodium channels. J Biol Chem 1998; 273: 27076-83.
72. Bosmans F, Tytgat J. Voltage-gated sodium channel modulation by scorpion alpha-toxins. Toxicon 2007; 49: 142-58.
73. Gordon D, Martin-Eauclaire MF, Cestele S, Kopeyan C, Carlier E, Khalifa RB, et al. Scorpion toxins affecting sodium current inactivation bind to distinct homologous receptor sites on rat brain and insect sodium channels. J Biol Chem 1996, 271: 8034-45.
74. Gordon D, Savarin P, Gurevitz M, Zinn-justin S. Functional anatomy of scorpion toxins affecting sodium channels. J Toxicol Toxin Rev 1998; 17: 131-59.
75. Gordon D, Karbat I, Ilan N, Cohen L, Kahn R, Gilles N, et al. The differential preference of scorpion alpha-toxins for insect or mammalian sodium channels: implications for improved insect control. Toxicon 2007;49:452-72.
76. Karbat I, Turkov M, Cohen L, Kahn R, Gordon D, Gurevitz M, et al. X-ray structure and mutagenesis of the scorpion depressant toxin LqhIT2 reveals key determinants crucial for activity and anti-insect selectivity. J Mol Biol 2007; 366: 586-601.
77. Rochat H, Rochat C, Sampieri F, Miranda F, Lissitzky S. The amino-acid sequence of neurotoxin II of Androctonus australis Hector. Eur J Biochem 1972; 28: 381-8.
78. Legros C, Ceard B, Vacher H, Marchot P, Bougis PE, Martin-Eauclaire MF. Expression of the standard scorpion alpha-toxin AaH II and AaH II mutants leading to the identification of some key bioactive elements. Biochim Biophys Acta 2005; 1723: 91-9.
79. Chen H, Lu S, Leipold E, Gordon D, Hansel A, Heinemann SH. Differential sensitivity of sodium channels from the central and peripheral nervous system to the scorpion toxins Lqh-2 and Lqh-3. Eur J Neurosci 2002; 16: 767-70.
80. Li YJ, Ji YH. Binding characteristics of BmK I, an alpha-like scorpion neurotoxic polypeptide, on cockroach nerve cord synaptosomes. J Pept Res 2000; 56: 195-200.
81. Goudet C, Huys I, Clynen E, Schoofs L, Wang DC, Waelkens E, et al. Electrophysiological characterization of BmK M1, an alpha-like toxin from Buthus martensi Karsch venom. FEBS Lett 2001; 495: 61-5.
82. + currents in isolated dorsal unpaired median neurons of Locusta, migratoria and effect of the alpha-like scorpion toxin. BmK M1. J Insect Physiol 2003; 49: 171-82.
83. Bosmans F, Brone B, Sun YM, Zhu RH, Xiong YM, Wang DC, et al. Pharmacological comparison of two different insect models using the scorpion alpha-like toxin BmK M1 from Buthus martensii Karsch. Protein Pept Lett 2005; 12: 363-7.
84. Sautiere P, Cestele S, Kopeyan C, Martinage A, Drobecq H, Doljansky Y, et al. New toxins acting on sodium channels from the scorpion Leiurus quinquestriatus hebraeus suggest a clue to mammalian vs insect selectivity. Toxicon 1998; 36: 1141-54.
85. Eitan M, Fowler E, Herrmann R, Duval A, Pelhate M, Zlotkin E. A scorpion venom neurotoxin paralytic to insects that affects sodium current inactivation: purification, primary structure, and mode of action. Biochemistry 1990; 29: 5941-7.
86. Vargas O, Martin MF, Rochat H. Characterization of six toxins from the venom of the Moroccan scorpion Buthus occitanus mardochei, Eur J Biochem, 1987; 162: 589-99.
87. Cestele S, Catterall WA. Molecular mechanisms of neurotoxin action on voltage-gated sodium channels. Biochimie 2000; 82: 993-92.
88. Bosmans F, Martin-Eauclaire MF, Tytgat J. Differential effects of five 'classical' scorpion beta-toxins on rNav1.2a and DmNav1 provide clues on species-selectivity. Toxicol Appl Pharmacol 2007; 218: 45-51.
89. Gurevitz M, Karbat I, Cohen L, Ilan N, Kahn R, Turkov M, et al. The insecticidal potential of scorpion beta-toxins, Toxicon 2007; 49: 473-89.
90. Martin MF, Garcia y Perez LG, el Ayeb M, Kopeyan C, Bechis G, Jover E, et al. Purification and chemical and biological characterizations of seven toxins from the Mexican scorpion, Centruroides suffusus suffusus. J Biol Chem 1987; 262: 4452-9.
91. + channel. J Biol Chem 1982; 257: 12553-8.
92. Beehis G, Sampieri F, Yuan PM, Brando T, Martin MF, Diniz CR, et al. Amino acid sequence of toxin VII, a-beta-toxin from the venom of the scorpion Tityus serrulatus. Biochem Biophys Res Commun 1984; 122:1146-53.
93. Ceard B, De Lima ME, Bougis PE, Martin-Eauclaire ME Purification of the main beta-toxin from Tityus serrulatus scorpion venom using high-performance liquid chromatography. Toxicon 1992; 30: 105-10.
94. De Lima ME, Martin MF, Diniz CR, Rochat H. Tityus serrulatus toxin VII bears pharmacological properties of both beta-toxin and insect toxin from scorpion venoms. Biochem Biophys Res Commun 1986; 139:296-302.
95. Gordon D, Ilan N, Zilberberg N, Gilles N, Urbach D, Cohen L, et al. An 'Old World' scorpion beta-toxin that recognizes both insect and mammalian sodium channels. Eur J Biochem 2003; 270: 2663-70.
96. Shichor I, Zlotkin E, Ilan N, Chikashvili D, Stuhmer W, Gordon D, et al. Domain 2 of Drosophila para voltage-gated sodium channel confers insect properties to a rat brain channel. J Neurosci 2002; 22:4364-71.
97. + channels. FASEB J 2004; 18: 683-9.
98. Froy O, Zilberberg N, Gordon D, Turkov M, Gilles N, Stankiewicz K et al. The putative bioactive surface of insect-selective scorpion excitatory neurotoxins. J Biol Chem 1999; 274: 5769-76.
99. Bosmans F, Martin-Eauclaire MF, Tytgat J. The depressant scorpion neurotoxin LqqlT2 selectively modulates the insect voltage-gated sodium channel. Toxicon 2005; 45: 501-7.
100. Zlotkin E, Gurevitz M, Fowler E, Adams ME. Depressant insect selective neurotoxins from scorpion venom: chemistry, action, and gene cloning. Arch Insect Biochem Physiol 1993; 22: 55-73.
101. Cohen L, Troub Y, Turkov M, Gilles N, Ilan N, Benveniste M, et al. Mammalian skeletal muscle voltage-gated sodium channels are affected by scorpion depressant "insect-selective" toxins when preconditioned. Mol Pharmacol 2007; 72: 1220-7.
102. Mebs D. Venomous and poisonous animals: a handbook for biologists, toxicologists and toxinologists, physicians and pharmacists. Stutigart, Medpharin Scientific Publishers, 2002.
103. Terlau H, Olivera BM. Conus venoms: a rich source of novel ion channel-targeted peptides. Physiol Rev 2004; 84: 41-68.
104. Terlau H, Shon KJ, Grilley M, Stocker M, Stuhmer W, Olivera BM. Strategy for rapid immobilization of prey by a fish-hunting marine snail. Nature 1996; 381: 148-51.
105. McIntosh JM, Jones RM. Cone venom-from accidental stings to deliberate injection. Toxicon 2001; 39: 1447-51.
106. Nelson L. Venomous snails: one slip, and you're dead. Nature 2004; 429: 798-9.
107. Norton RS, Olivera BM. Conotoxins down under. Toxicon 2006; 48: 780-98.
108. Olivera BM. Conus peptides: biodiversity-based discovery and exogenomics. J Biol Chem 2006; 281: 31173-7.
109. Honma T, Shiomi K. Peptide toxins in sea anemones: structural and functional aspects. Mar Biotechnol 2006; 8: 1-10.
110. Estrada G, Villegas E, Corzo G. Spider venoms: a rich source of acylpolyamines and peptides as new leads for CNS drugs. Nat Prod Rep 2007; 24: 145-61.
111. Armishaw CJ, Alewood PF. Conotoxins as research tools and drug leads. Curr Protein Pept Sci 2005; 6: 221-40.
112. Heinemann SH, Leipold E. Conotoxins of the O-superfamily affecting voltage-gated sodium channels. Cell Mol Life Sci 2007; 64: 132940.
113. Livett BG, Gayler KR, Khalil Z. Drugs from the sea: conopeptides as potential therapeutics. Curr Med Chem 2004; 11: 1715-23.
114. Lewis RJ. Conotoxins as selective inhibitors of neuronal ion channels, receptors and transporters. IUBMB Life 2004; 56: 89-93.
115. Ekberg J, Craik DJ, Adams DJ. Conotoxin modulation of voltage-gated sodium channels. Int J Biochem Cell Biol 2007 [Epub ahead of print].
116. Li RA, Tomaselli GF. Using the deadly mu-conotoxins as probes of voltage-gated sodium channels. Toxicon 2004; 44: 117-22.
117. Moczydlowski E, Olivera BM, Gray WR, Strichartz GR. Discrimination of muscle and neuronal Na-channel subtypes by binding competition between [3H]saxitoxin and mu-conotoxins. Proc Natl Acad Sci USA 1986; 83 5321-5.
118. Yanagawa Y, Abe T, Satake M. Mu-conoloxins share a common binding site with tetrodotoxin/saxitoxin on eel electroplax Na channels. J Neurosci 1987; 7: 1498-502.
119. Cruz LJ, Kupryszewski G, LeCheminant GW, Gray WR, Olivera BM, Rivier J. mu-conotoxin GIIIA, a peptide ligand for muscle sodium channels: chemical synthesis, radiolabeling, and receptor characterization. Biochemistry 1989; 28: 3437-42.
120. + channel predict a clockwise arrangement of the domains. J Gen Physiol 2000; 116: 679-90.
121. Li RA, Ennis IL, French RJ, Dudley SC, Jr., Tomaselli GF, Marban E. Clockwise domain arrangement of the sodium channel revealed by (mu)-conotoxin (GIIIA) docking orientation. J Biol Chem 2001; 276: 11072-7.
122. + channels. J Biol Chem 2003; 278: 8717-24.
123. + channel domain I P-loop: implications for toxin-pore binding geometry. Biophys J 2003; 85: 2299-310.
124. Cruz LJ, Gray WP, Olivera BM, Zeikus RD, Kerr L, Yoshikami D, et al. Conus geographus toxins that discriminate between neuronal and muscle sodium channels. J Biol Chem 1985; 260: 9280-8.
125. Hill JM, Alewood PF, Craik DJ. Three-dimensional solution structure of mu-conotoxin GIIIB, a specific blocker of skeletal muscle sodium channels. Biochemistry 1996; 35:8824-35.
126. Lewis RJ, Schroeder CI, Ekberg J, Nielsen KJ, Loughnan M, Thomas L, et al. Isolation and structure-activity of mu-conotoxin TI-IIA, a potent inhibitor of tetrodotoxin-sensitive voltage-gated sodium channels. Mol Pharmacol 2007; 71: 676-85.
127. Safo P, Rosenbaum T, Shcherbatko A, Choi DY, Han E, Toledo-Aral JJ, et al. Distinction among neuronal subtypes of voltage-activated sodium channels by mu-conotoxin PIIIA. J Neurosci 2000; 20: 76-80.
128. Shon KJ, Olivera BM, Watkins M, Jacobsen RB, Gray WR, Floresca CZ, et al. mu-Conotoxin PIIIA, a new peptide for discriminating among tetrodotoxin-sensitive Na channel subtypes. J Neurosci 1998; 18: 4473-81.
129. Nielsen KJ, Watson M, Adams DJ, Hammarstrom AK, Gage PW, Hill JM, et al. Solution structure of mu-conotoxin PIIIA, a preferential inhibitor of persistent tetrodotoxin-sensitive sodium channels. J Biol Chem 2002; 277: 27247-55.
130. West PJ, Bulaj G, Garrett JE, Olivera BM, Yoshikami D. Muconotoxin SmIIIA, a potent inhibitor of tetrodotoxin-resistant sodium channels in amphibian sympathetic and sensory neurons. Biochemistry 2002; 41: 15388-93.
131. Keizer DW, West PJ, Lee EF, Yoshikami D, Olivera BM, Bulaj G, et al. Structural basis for tetrodotoxin-resistant sodium channel binding by mu-conotoxin SmIIIA. J Biol Chem 2003; 278: 46805-13.
132. Bulaj G, West PJ, Garrett JE, Watkins M, Zhang MM, Norton RS, et al. Novel conotoxins from Conus striatus and Conus kinoshitai selectively block TTX-resistant sodium channels. Biochemistry 2005; 44: 7259-65.
133. Wang CZ, Zhang H, Jiang H, Lu W, Zhao ZQ, Chi CW. A novel conotoxin from Conus striatus, mu-SIIIA, selectively blocking rat tetrodotoxin-resistant sodium channels. Toxicon 2006; 47: 122-32.
134. Zhang MM, Fiedler B, Green BR, Catlin P, Watkins M, Garrett JE, et al. Structural and functional diversities among mu-conotoxins targeting TTX-resistant sodium channels. Biochemistry 2006; 45: 3723-32.
135. Zhang MM, Green BR, Catlin P, Fiedler B, Azam L, Chadwick A, et al. Structure/function characterization of micro-conotoxin KIIIA, an analgesic, nearly irreversible blocker of mammalian neuronal sodium channels. J Biol Chem 2007; 282: 30699-706.
136. Kohno T, Sasaki T, Kobayashi K, Fainzilber M, Sato K. Three-dimensional solution structure of the sodium. channel agonist/antagonist delta-conotoxin TxVIA. J Biol Chem 2002; 277: 36387-91.
137. Nielsen KJ, Thomas L, Lewis RJ, Alewood,PF, Craik DJ. A consensus structure for omega-conotoxins with different selectivities for voltage-sensitive calcium channel subtypes: comparison of MVIIA, SVIB and SNX-202. J Mol Biol 1996; 263: 297-310.
138. Daly NL, Ekberg JA, Thomas L, Adams DJ, Lewis RJ, Craik DJ. Structures of muO-conotoxins from Conus marmoreus. Inhibitors of tetrodotoxin (TTX)-sensitive and TTX-resistant sodium channels in mammalian sensory neurons. J Biol Chem 2004; 279: 25774-82.
139. McIntosh JM, Hasson A, Spira ME, Gray WP, Li W, Marsh M, et al. A new family of conotoxins that blocks voltage-gated sodium channels. J Biol Chem 1995; 270: 16796-802.
140. Terlau H, Stocker M, Shon KJ, McIntosh JM, Olivera BM. MicroO-conotoxin MrVIA inhibits mammalian sodium channels, but not through site I. J Neurophysiol 1996; 76: 1423-9.
141. Zorn S, Leipold E, Hansel A, Bulaj G, Olivera BM, Terlau H, et al. The muO-conotoxin MrVIA inhibits voltage-gated sodium channels by associating with domain-3. FEBS Lett 2006; 580: 1360-4.
142. Fainzilber M, van der Schors R, Lodder JC, Li KW, Geraerts WP, Kits KS. New sodium channel-blocking conotoxins also affect calcium currents in Lymnaea neurons. Biochemistry 1995; 34: 5364-71.
143. v1.8 and has a long-lasting analgesic activity. Biochemistry 2006; 45: 7404-14.
144. Ekberg J, Jayamanne A, Vaughan CW, Aslan S, Thomas L, Mould J, et al. muO-conotoxin MrVIB selectively blocks Nav1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits. Proc Natl Acad Sci USA 2006; 103: 17030-5.
145. Nicholson GM, Little MJ, Birinyi-Strachan, LC. Structure and function of delta-atracotoxins: lethal neurotoxins targeting the voltage-gated sodium channel. Toxicon 2004; 43: 587-99.
146. Fainzilber M, Kofman O, Zlotkin E, Gordon D. A new neurotoxin receptor site on sodium channels is identified by a conotoxin that affects sodium channel inactivation in molluscs and acts as an antagonist in rat brain. J Biol Chem 1994; 269: 2574-80.
147. Fainzilber M, Lodder JC, Kits KS, Kofman O, Vinnitsky I, Van Rietschoten J, et al. A new conotoxin affecting sodium current inactivation interacts with the delta-conotoxin receptor site. J Biol Chem 1995; 270: 1123-9.
148. Leipold E, Hansel A, Olivera BM, Terlau H, Heinemann SH. Molecular interaction of delta-conotoxin with voltage-gated sodium channels. FEBS Lett 2005; 579: 3881-4.
149. Hillyard DR, Olivera BM, Woodward S, Corpuz GP, Gray WR, Ramilo CA, et al. A molluscivorous Conus toxin: conserved frameworks in conotoxins. Biochemistry 1989; 28: 358-61.
150. Shon KJ, Hasson A, Spira ME, Cruz LJ, Gray WR, Olivera BM. Delta-conotoxin Gm VIA, a novel peptide from the venom of Conus gloriamaris. Biochemistry 1994; 33: 11420-5.
151. Hasson A, Shon KJ, Olivera BM, Spira ME. Alterations of voltage-activated sodium current by a novel conotoxin from the venom of Conus gloriamaris. J Neurophysiol 1995; 73: 1295-301.
152. Shichor I, Fainzilber M, Pelhate M, Malecot CO, Zlotkin E, Gordon D. Interactions of delta-conotoxins with alkaloid neurotoxins reveal differences between the silent and effective binding sites on voltage-sensitive sodium channels. J Neurochem 1996; 67: 2451-60.
153. + channels but not in skeletal and cardiac muscles. J Biol Chem 2004; 279: 4680-5.
154. + channels. J Biol Chem 2004, 279: 21356-66.
155. Buczek O, Yoshikami D, Watkins M, Bulaj G, Jimenez EC, Olivera BM. Characterization of D-amino-acid-containing excitatory conotoxins and redefinition of the I-conotoxin superfamily. Febs J 2005; 272: 4178-88.
156. Jimenez EC, Shetty RP, Lirazan M, Rivier J, Walker C, Abogadic FC, et al. Novel excitatury Conus peptides define a new conotoxin superfamily. J Neurochem 2003; 85: 610-21.
157. Buczek O, Wei D, Babon JJ, Yang X, Fiedler B, Chen P, et al. Structure and sodium channel activity of an excitatory II-superfamily conotoxin. Biochemistry 2007; 46: 9929-40.
158. Pallaghy PK, Alewood D, Alewood PF, Norton RS. Solution structure of robustoxin, the lethal neurotoxin from the funnel-web spider Atrax robustus. FEBS Lett 1997; 419: 191-6.
159. Fletcher JI, Chapman BE, Mackay JP, Howden ME, King GF. The structure of versutoxin (delta-atracotoxin-Hv1) provides insights into the binding of site 3 neurotoxins to the voltage-gated sodium channel. Structure 1997; 5: 1525-35.
160. Kass RS, Moss AJ. Mutation-specific pharmacology of the long QT syndrome. Handb Exp Pharmacol 2006: 287-304.
161. Maier SK, Westenbroek RE, Yamanushi TT, Dobrzynski H, Boyett MR, Catterall WA, et al. An unexpected requirement for brain-type sodium channels for control of heart rate in the mouse sinoatrial node. Proc Natl Acad Sci USA 2003; 100: 3507-12.
162. Bosmans F, Rash L, Zhu S, Dinchot S, Lazdunski M, Escoubas P, et al. Four novel tarantula toxins as selective modulators of voltage-gated sodium channel subtypes. Mol Pharmacol 2006; 69: 419-29.
163. Cox J, Reimann F, Nicholas A, Thorntonm G, Roberts E, Springell K, et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature, 2006; 444: 894-98.
164. Fertleman C, Baker M, Parker K, Moffatt S, Elmslie F, Abrahamsen B, et al. SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 2006; 52: 767-74.
165. Akopian AN, Souslova V, England S, Okuse K, Ogata N, Ure J, et al. The tetrodotoxin-resistapt sodium channel SNS has a specialized function in pain pathways. Nat Neurosci 1999; 2: 541-8.
166. v1.9/NaN in afferent neurons innervating urinary bladder in control and spinal cord injured rats. Brain Res 2003; 963: 132-8.
167. Dib-Hajj S, Black JA, Cummins TR, Waxman SG. NaN/Nav1.9: a sodium channel with unique properties. Trends Neurosci 2002; 25: 253-9.
168. Hains BC, Klein JP, Saab CY, Craner MJ, Black JA, Waxman SG. Upregulation of sodium channel Nav1.3 and functional involvement in neuronal hyperexcitability associated with central neuropathic pain after spinal cord injury. J Neurosci 2003; 23: 8881-92.
169. Wood JN, Boorman JP, Okuse K, Baker MD. Voltage-gated sodium channels and pain pathways. J Neurobiol 2004; 61: 55-71.
170. Xiong YM, Lan ZD, Wang M, Liu B, Liu XQ, Fei H, et al. Molecular characterization of a new excitatory insect neurotoxin with an analgesic effect on mice from the scorpion Buthus martensi Karsch. Toxicon 1999; 37: 1165-80.
171. Guan RJ, Wang M, Wang D, Wang DC. A new insect neurotoxin AngP1 with analgesic effect from the scorpion Buthus martensii Karsch: purification and characterization. J Pept Res 2001; 58: 27-35.
172. Bai ZT, Liu T, Pang XY, Chai ZF, Ji YH. Suppression by intrathecal BmK IT2 on rat spontaneous pain behaviors and spinal c-Fos expression induced by formalin. Brain Res Bull 2007; 73: 248-53.
173. Wang CY, Tan ZY, Chen B, Zhao ZQ, Ji YH. Antihyperalgesia effect of BmK IT2, a deprasant insect-selective scorpion toxin in rat by peripheral administration. Brain Res Bull 2000; 53: 335-8.
174. Zhang XY, Bai ZT, Chai ZF, Zhang SW, Liu Y, Ji YH. Suppressive effects of BmK IT2 on nociceptive behavior and c-Fos expression in spinal cord induced by formalin. J Neurosci Res 2003; 74: 167-73.
175. Guan R, Wang CG, Wang M, Wang DC. A depressant insect toxin with a novel analgesic effect from scorpion Buthus matensii Karsch. Biochim Biophys Acta 2001; 1549: 9-18.
176. Liu YF, Ma RL, Wang SL, Duan ZY, Zhang JH, Wu LJ, et al. Expression of an antitumor-analgesic peptide from the venom of Chinese scorpion Buthus martensii karsch in Escherichia coli. Protein Expr Purif 2003; 27: 253-8.
177. 2+-release channel activity of the skeletal-muscle ryanodine receptor by an indirect mechanism. Biochem J 1999; 339: 343-50.
178. 3H]noradrenaline release from rat hippocampal slices. Biomed. Res. 1997; 18: 257-60.
179. + currents in dorsal root ganglion neurons. Neurosci Lett 2001; 297: 65-8.
180. Chen B, Ji Y. Antihyperalgesia effect of BmK AS, a scorpion toxin, in rat by intraplantar injection. Brain Res 2002; 952: 322-6.
181. Shao J, Kang N, Liu Y, Song S, Wu C, Zhang J. Purification and characterization of an analgesic peptide from Buthus martensii Karsch. Biomed Chromatogr 2007; 21: 1266-71.
182. + channels. Neuropharmacology 2001; 40: 352-7.
183. + channels in B104 neuronal cell line. Neurosci Lett 2003; 340: 123-6.
184. + currents in primary afferent neurons. Peptides 2006; 27: 2182-92.
185. + channels. FEBS Lett 2005; 579: 4181-6.
186. Maertens C, Cuypers E, Amininasab M, Jalali A, Vatanpour H, Tytgat J. Potent modulation of the voltage-gated sodium channel Nav1.7 by OD1, a toxin from the scorpion Odonthobuthus doriae. Mol Pharmacol 2006; 70: 405-14.
187. McCorry D, Chadwick D, Marson A. Current drug treatment of epilepsy in adults. Lancet Neurol 2004; 3: 729-35.
188. Mortari MR, Cunha AO, Ferreira LB, dos Santos WF. Neurotoxins from invertebrates as anticonvulsants: from basic research to therapeutic application. Pharmacol Ther 2007; 114: 171-83.
189. Meisler MH, Kearney JA. Sodium channel mutations in epilepsy and other neurological disorders. J Clin Invest 2005; 115: 2010-7.
190. Zhou XH, Yang D, Zhang JH, Liu CM, Lei KJ. Purification and N-terminal partial sequence of anti-epilepsy peptide from venom of the scorpion Buthus martensii Karsch. Biochem J 1989; 257: 509-17.
191. Wang CG, He XL, Shao,F, Liu W, Ling MH, Wang DC, et al. Molecular characterization of an anti-epilepsy peptide from the scorpion Buthus martensi Karsch. Eur J Biochem 2001; 268: 2480-5.
192. Corona M, Coronas FV, Merino E, Becerril B, Gutierrez R, Rebolledo-Antunez S, et al. A novel class of peptide found in scorpion venom with neurodepressant effects in peripheral and central nervous system of the rat. Biochim Biophys Acta 2003; 1649: 58-67.
193. Rajendra W, Armugam A, Jeyaseelan K. Toxins in anti-nociception and anti-inflammation. Toxicon 2004; 44: 1-17.
194. Green BR, Catlin P, Zhang MM, Fiedler B, Bayadan W, Morrison A, et al. Conotoxins containing nonnatural backbone spacers: cladistic-based design, chemical synthesis, and improved analgesic activity. Chem Biol 2007; 14: 399-407.
195. + channel. Science 2005; 309: 897-903.
196. v1.2: structural basis of electromechanical coupling. Science 2005; 309: 903-8.
197. Nicholson GM. Insect-selective spider toxins targeting voltage-gated sodium channels. Toxicon 2007; 49: 490-512.
198. Bersudsky Y. Phenytoin: an anti-bipolar anticonvulsant? Int J Neuropsychopharmacol 2006; 9(4): 479-84.
199. Fox JW, Serrano SM. Approaching the golden age of natural product pharmaceuticals from venom libraries: an overview of toxins and toxin-derivatives currently involved in therapeutic or diagnostic applications. Curr Pharm Des 2007; 13(28): 2927-34.
200. Wilms H, Zecca L, Rosenstiel P, Sievers J, Deuschl G, Lucius R. Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications. Curr Pharm Des 2007; 13(18): 1925-8.